Germline RET variants underlie a subset of paediatric osteosarcoma.
Michal KovacConnor WoolleySebastian RibiClaudia BlattmannEva RothMarco MoriniMonika KovacovaBaptiste AmelineAndreas KulozikStefan BielackWolfgang HartmannMandy L BallingerDavid M ThomasIan TomlinsonMichaela NathrathKarl HeinimannDaniel BaumhoerPublished in: Journal of medical genetics (2020)
After Li-Fraumeni-predisposing mutations in TP53, RET becomes the second most mutated cancer-predisposing gene in the germline of patients with osteosarcoma. Hence, early identification of RET mutation carriers can help to identify at-risk family members and carry out preventive measures.